Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TScan Therapeutics, Inc. | Vice President, Finance | Stock Option (Right to Buy) | 46.9K | Jan 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TCRX | TScan Therapeutics, Inc. | Jan 12, 2024 | 1 | $0 | 4 | Feb 11, 2025 | Vice President, Finance |
TCRX | TScan Therapeutics, Inc. | Jul 21, 2023 | 1 | $0 | 4 | Jul 24, 2023 | Chief Accounting Officer |
TCRX | TScan Therapeutics, Inc. | Jul 21, 2023 | 0 | $0 | 3 | Jul 24, 2023 | Chief Accounting Officer |